Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure

被引：0
|
作者：
Nice, R. [1 ,2 ]
Goodhand, J. R. [2 ,3 ]
Kennedy, N. [2 ,3 ]
Ahmad, T. [2 ]
Winyard, P. [2 ]
McDonald, T. J. [1 ,2 ]
机构：
[1] Royal Devon & Exeter NHS Fdn Trust, Blood Sci, Exeter, Devon, England
[2] Univ Exeter, Med Sch, Exeter, Devon, England
[3] Royal Devon & Exeter NHS Fdn Trust, Gastroenterol, Exeter, Devon, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P196
引用
收藏
页码：I256 / I256
页数：1
相关论文
共 50 条
  • [41] Adalimumab As First-Line Anti-TNF Treatment in Pediatric Crohn's Disease
    Martin-de-Carpi, Javier
    Navas-Lopez, Victor
    Navalon-Rubio, Maria
    Llerena-Santa-Cruz, Enrique
    Ortega, David Gil
    Varea-Calderon, Vicente
    Sierra-Salinas, Carlos
    GASTROENTEROLOGY, 2014, 146 (05) : S780 - S780
  • [42] ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB
    Kappelman, Michael
    Wohl, David A.
    Herfarth, Hans
    Firestine, Ann M.
    Adler, Jeremy
    Steiner, Steven J.
    Colletti, Richard B.
    Park, K. T.
    Grossman, Andrew B.
    Ivanova, Anastasia
    Galanko, Joseph
    Osaba, Lourdes
    Chun, Kelly Y.
    Weinberger, Morris
    Margolis, Peter
    Saeed, Shehzad
    Bousvaros, Athos
    GASTROENTEROLOGY, 2023, 164 (06) : S168 - S169
  • [43] Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD
    Frederiksen, Madeline Therese
    Ainsworth, Mark Andrew
    Brynskov, Jorn
    Thomsen, Ole Ostergaard
    Bendtzen, Klaus
    Steenholdt, Casper
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (10) : 1714 - 1721
  • [44] Vascular endothelial dysfunction in rheumatoid arthritis is improved by anti-TNFα treatment with infliximab.
    Forster, A
    Hürlimann, D
    Ruschitzka, F
    Enseleit, F
    Noll, G
    Lüscher, TF
    Michel, N
    Distler, O
    Brühlmann, P
    Michel, BM
    Gay, RE
    Gay, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S511 - S511
  • [45] EFFECT ON SLEEP OF ANTI-TNF alpha TREATMENT (INFLIXIMAB) IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
    Maceiras, F.
    Zamarron, C.
    Amarelo, J.
    Mera, A.
    Gomez-Reino, J. J.
    RHEUMATOLOGY, 2002, 41 : 72 - 72
  • [46] Recommendations for tuberculosis screening and treatment of latent tuberculosis in case of anti-TNFα-therapie with infliximab
    Hülsemann, JL
    Hohlfeld, JM
    Schnarr, S
    Stoll, M
    Zeidler, H
    AKTUELLE RHEUMATOLOGIE, 2002, 27 (02) : 97 - 100
  • [47] Anti-TNF biosimilars in psoriasis treatment
    Viguier, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (6-7): : 492 - 496
  • [48] Is psoriasis a complication of anti-TNF treatment?
    Perez-Zafrilla, Beatriz
    Garcia de Yebenes, Maria Jess
    Dauden, Esteban
    Gomez-Reino, Juan J.
    Carmona, Loreto
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S781 - S781
  • [49] Anti-TNF Agents for the Treatment of Psoriasis
    Kircik, Leon H.
    Del Rosso, James Q.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (06) : 546 - 559
  • [50] Anti-TNF therapeutics for the treatment of sarcoidosis
    Crommelin, Heleen A.
    Vorselaars, Adriane D. M.
    van Moorsel, Coline H. M.
    Korenromp, Ingrid H. E.
    Deneer, Vera H. M.
    Grutters, Jan C.
    IMMUNOTHERAPY, 2014, 6 (10) : 1127 - 1143
12345